TECFIDERA® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis 3 Feb 2014 Accessed on 13 Feb 2014 from https://www.biogenidec.com/press_release_details.aspx?ID=14712&Action=1&NewsId=2286&M=NewsV2&PID=61997. CommentRecommendBookmarkWatch